New Findings from National School of Public Health in the Area of Health and Society Reported (Why do generic drugs fail to achieve an adequate market share in Greece? Empirical findings and policy suggestions)
By a News Reporter-Staff News Editor at Health & Medicine Week Researchers detail new data in Health and Medicine - Health and Society. According to news reporting from Athens, Greece, by NewsRx journalists, research stated, "Since 2010, the memoranda of understanding were implemented in Greece as a measure of fiscal adjustment. Public pharmaceutical expenditure was one of the main focuses of this implementation."
Financial support for this research came from MSD Greece (see also Health and Medicine - Health and Society).
The news correspondents obtained a quote from the research from the National School of Public Health, "Numerous policies, targeted on pharma spending, reduced the pharmaceutical budget by 60.5%. Yet, generics' penetration in Greece remained among the lowest among OECD countries. This study aims to highlight the factors that affect the perceptions of the population on generic drugs and to suggest effective policy measures. The empirical analysis is based on a national cross-sectional survey that was conducted through a sample of 2003 individuals, representative of the general population. Two ordinal logistic regression models were constructed in order to identify the determinants that affect the respondents' beliefs on the safety and the effectiveness of generic drugs. The empirical findings presented a positive and statistically significant correlation with income, bill payment difficulties, safety and effectiveness of drugs, prescription and dispensing preferences and the views toward pharmaceutical companies. Also, age and trust toward medical community have a positive and statistically significant correlation with the perception on the safety of generic drugs."
According to the news reporters, the research concluded: "Policy interventions are suggested on the bases of the empirical results on 3 major categories; (a) information campaigns, (b) incentives to doctors and pharmacists and to strengthen the bioequivalence control framework and the dissemination of results."
For more information on this research see: Why do generic drugs fail to achieve an adequate market share in Greece? Empirical findings and policy suggestions. Health Policy, 2017;121(3):265-272. Health Policy can be contacted at: Elsevier Ireland Ltd, Elsevier House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000, Ireland. (Elsevier - www.elsevier.com; Health Policy - www.journals.elsevier.com/health-policy/)
Our news journalists report that additional information may be obtained by contacting A. Charonis, Natl Sch Public Hlth, Dept. of Hlth Econ, Athens 11521, Greece. Additional authors for this research include A. Charonis, K. Athanasakis, J. Kyriopoulos and E. Pavi.
Keywords for this news article include: Athens, Greece, Europe, Health and Society, Health and Medicine, Drugs and Therapies, National School of Public Health.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC